1 | hospitalization | 7,776 |
2 | hospitalizations | 2,187 |
3 | readmission | 1,208 |
4 | reoperation | 1,177 |
5 | hospitalisation | 1,149 |
6 | rehospitalization | 550 |
7 | readmissions | 548 |
8 | stillbirth | 493 |
9 | hospitalisations | 352 |
10 | reintervention | 310 |
11 | reoperations | 281 |
12 | re-operation | 228 |
13 | incarceration | 173 |
14 | reintubation | 139 |
15 | rehospitalizations | 136 |
16 | re-intervention | 98 |
17 | reinterventions | 96 |
18 | re-hospitalization | 91 |
19 | re-admission | 88 |
20 | sick-leave | 60 |
21 | rehospitalisation | 57 |
22 | re-exploration | 49 |
23 | recatheterization | 41 |
24 | re-admissions | 39 |
25 | re-intubation | 31 |
26 | fussing | 29 |
27 | re-laparotomy | 28 |
28 | re-interventions | 25 |
29 | re-hospitalisation | 24 |
30 | reexploration | 24 |
31 | 16h | 20 |
32 | re-excision | 20 |
33 | adenotonsillectomies | 18 |
34 | re-hospitalizations | 18 |
35 | re-catheterization | 15 |
36 | recatheterisation | 14 |
37 | reexcision | 11 |
38 | sick-listing | 11 |
39 | cbmcr | 9 |
40 | hypomenorrhea | 9 |
41 | reconsultations | 9 |
42 | false-negatives | 8 |
43 | pressors | 8 |
44 | re-consultation | 8 |
45 | regrafting | 8 |
46 | death/htx | 7 |
47 | reincarceration | 7 |
48 | rs10490924 | 7 |
49 | depolarisations | 6 |
50 | move-in | 6 |
51 | sr13668 | 6 |
52 | whole- | 6 |
53 | 4-hydroxybenzoate | 5 |
54 | alpha-casein | 5 |
55 | inquest | 5 |
56 | laparoconversion | 5 |
57 | magnesiuria | 5 |
58 | murad | 5 |
59 | pregabaline | 5 |
60 | re-catheterisation | 5 |
61 | urethrolysis | 5 |
62 | anti-saccades | 4 |
63 | hst-3.1 | 4 |
64 | immunotherapy/biotherapy | 4 |
65 | paramomycin | 4 |
66 | retocolysis | 4 |
67 | squirts | 4 |
68 | sulphalene | 4 |
69 | thermocyling | 4 |
70 | 1.6:1 | 3 |
71 | 2.9-w/kg | 3 |
72 | 3.5years | 3 |
73 | alt≥3×uln | 3 |
74 | autumn/winter | 3 |
75 | canalplasty | 3 |
76 | cva16 | 3 |
77 | dna-testing | 3 |
78 | ecmo/death | 3 |
79 | frigidity | 3 |
80 | global- | 3 |
81 | halazoline | 3 |
82 | hyperthermia-βb | 3 |
83 | mc-lf | 3 |
84 | muroctasin | 3 |
85 | nurse-training | 3 |
86 | per-month | 3 |
87 | peri-conception | 3 |
88 | rubricytosis | 3 |
89 | 0.9935 | 2 |
90 | 360min | 2 |
91 | 70months | 2 |
92 | abaa | 2 |
93 | antimicrobial-days | 2 |
94 | azilsartan-gln | 2 |
95 | dalteparin-sodium | 2 |
96 | event/hospitalization | 2 |
97 | five-months | 2 |
98 | handrails | 2 |
99 | hot-consolidation | 2 |
100 | hypotensor | 2 |
101 | l253f | 2 |
102 | no-mdd-history | 2 |
103 | optifood | 2 |
104 | piezoelectricity | 2 |
105 | polydrugs | 2 |
106 | quantifiability | 2 |
107 | raltegravir/etravirine/maraviroc | 2 |
108 | re-scope | 2 |
109 | re-transplant | 2 |
110 | refavs | 2 |
111 | reocclusion-free | 2 |
112 | stoppages | 2 |
113 | thermoactinomycetes | 2 |
114 | tients | 2 |
115 | treatment-failures | 2 |
116 | vagotonia | 2 |
117 | ≤0.90 | 2 |
118 | 12609000966291 | 1 |
119 | 1970-86 | 1 |
120 | antibiotics-these | 1 |
121 | april-july | 1 |
122 | complications-small | 1 |
123 | ductoplasty | 1 |
124 | handbacks | 1 |
125 | interval-to-delivery | 1 |
126 | intervention/hospitalization | 1 |
127 | nurse-intervention | 1 |
128 | ofosteosynthesis | 1 |
129 | orchectomy | 1 |
130 | pieloplasty | 1 |
131 | questionnaire-mlhfq | 1 |
132 | re-circumcision | 1 |
133 | re-manipulation | 1 |
134 | re-transplantations | 1 |
135 | recall/repetition | 1 |
136 | trial.†ep | 1 |
137 | utermohlen | 1 |
1 | 0.9935 | 2 |
2 | 1.6:1 | 3 |
3 | 12609000966291 | 1 |
4 | 16h | 20 |
5 | 1970-86 | 1 |
6 | 2.9-w/kg | 3 |
7 | 3.5years | 3 |
8 | 360min | 2 |
9 | 4-hydroxybenzoate | 5 |
10 | 70months | 2 |
11 | abaa | 2 |
12 | adenotonsillectomies | 18 |
13 | alpha-casein | 5 |
14 | alt≥3×uln | 3 |
15 | anti-saccades | 4 |
16 | antibiotics-these | 1 |
17 | antimicrobial-days | 2 |
18 | april-july | 1 |
19 | autumn/winter | 3 |
20 | azilsartan-gln | 2 |
21 | canalplasty | 3 |
22 | cbmcr | 9 |
23 | complications-small | 1 |
24 | cva16 | 3 |
25 | dalteparin-sodium | 2 |
26 | death/htx | 7 |
27 | depolarisations | 6 |
28 | dna-testing | 3 |
29 | ductoplasty | 1 |
30 | ecmo/death | 3 |
31 | event/hospitalization | 2 |
32 | false-negatives | 8 |
33 | five-months | 2 |
34 | frigidity | 3 |
35 | fussing | 29 |
36 | global- | 3 |
37 | halazoline | 3 |
38 | handbacks | 1 |
39 | handrails | 2 |
40 | hospitalisation | 1,149 |
41 | hospitalisations | 352 |
42 | hospitalization | 7,776 |
43 | hospitalizations | 2,187 |
44 | hot-consolidation | 2 |
45 | hst-3.1 | 4 |
46 | hyperthermia-βb | 3 |
47 | hypomenorrhea | 9 |
48 | hypotensor | 2 |
49 | immunotherapy/biotherapy | 4 |
50 | incarceration | 173 |
51 | inquest | 5 |
52 | interval-to-delivery | 1 |
53 | intervention/hospitalization | 1 |
54 | l253f | 2 |
55 | laparoconversion | 5 |
56 | magnesiuria | 5 |
57 | mc-lf | 3 |
58 | move-in | 6 |
59 | murad | 5 |
60 | muroctasin | 3 |
61 | no-mdd-history | 2 |
62 | nurse-intervention | 1 |
63 | nurse-training | 3 |
64 | ofosteosynthesis | 1 |
65 | optifood | 2 |
66 | orchectomy | 1 |
67 | paramomycin | 4 |
68 | per-month | 3 |
69 | peri-conception | 3 |
70 | pieloplasty | 1 |
71 | piezoelectricity | 2 |
72 | polydrugs | 2 |
73 | pregabaline | 5 |
74 | pressors | 8 |
75 | quantifiability | 2 |
76 | questionnaire-mlhfq | 1 |
77 | raltegravir/etravirine/maraviroc | 2 |
78 | re-admission | 88 |
79 | re-admissions | 39 |
80 | re-catheterisation | 5 |
81 | re-catheterization | 15 |
82 | re-circumcision | 1 |
83 | re-consultation | 8 |
84 | re-excision | 20 |
85 | re-exploration | 49 |
86 | re-hospitalisation | 24 |
87 | re-hospitalization | 91 |
88 | re-hospitalizations | 18 |
89 | re-intervention | 98 |
90 | re-interventions | 25 |
91 | re-intubation | 31 |
92 | re-laparotomy | 28 |
93 | re-manipulation | 1 |
94 | re-operation | 228 |
95 | re-scope | 2 |
96 | re-transplant | 2 |
97 | re-transplantations | 1 |
98 | readmission | 1,208 |
99 | readmissions | 548 |
100 | recall/repetition | 1 |
101 | recatheterisation | 14 |
102 | recatheterization | 41 |
103 | reconsultations | 9 |
104 | reexcision | 11 |
105 | reexploration | 24 |
106 | refavs | 2 |
107 | regrafting | 8 |
108 | rehospitalisation | 57 |
109 | rehospitalization | 550 |
110 | rehospitalizations | 136 |
111 | reincarceration | 7 |
112 | reintervention | 310 |
113 | reinterventions | 96 |
114 | reintubation | 139 |
115 | reocclusion-free | 2 |
116 | reoperation | 1,177 |
117 | reoperations | 281 |
118 | retocolysis | 4 |
119 | rs10490924 | 7 |
120 | rubricytosis | 3 |
121 | sick-leave | 60 |
122 | sick-listing | 11 |
123 | squirts | 4 |
124 | sr13668 | 6 |
125 | stillbirth | 493 |
126 | stoppages | 2 |
127 | sulphalene | 4 |
128 | thermoactinomycetes | 2 |
129 | thermocyling | 4 |
130 | tients | 2 |
131 | treatment-failures | 2 |
132 | trial.†ep | 1 |
133 | urethrolysis | 5 |
134 | utermohlen | 1 |
135 | vagotonia | 2 |
136 | whole- | 6 |
137 | ≤0.90 | 2 |
1 | whole- | 6 |
2 | global- | 3 |
3 | ≤0.90 | 2 |
4 | hst-3.1 | 4 |
5 | 12609000966291 | 1 |
6 | 1.6:1 | 3 |
7 | rs10490924 | 7 |
8 | 0.9935 | 2 |
9 | cva16 | 3 |
10 | 1970-86 | 1 |
11 | sr13668 | 6 |
12 | abaa | 2 |
13 | hypomenorrhea | 9 |
14 | vagotonia | 2 |
15 | magnesiuria | 5 |
16 | hyperthermia-βb | 3 |
17 | raltegravir/etravirine/maraviroc | 2 |
18 | murad | 5 |
19 | optifood | 2 |
20 | reocclusion-free | 2 |
21 | sulphalene | 4 |
22 | pregabaline | 5 |
23 | halazoline | 3 |
24 | re-scope | 2 |
25 | antibiotics-these | 1 |
26 | 4-hydroxybenzoate | 5 |
27 | sick-leave | 60 |
28 | l253f | 2 |
29 | mc-lf | 3 |
30 | 2.9-w/kg | 3 |
31 | thermocyling | 4 |
32 | nurse-training | 3 |
33 | fussing | 29 |
34 | regrafting | 8 |
35 | dna-testing | 3 |
36 | sick-listing | 11 |
37 | 16h | 20 |
38 | ecmo/death | 3 |
39 | per-month | 3 |
40 | stillbirth | 493 |
41 | complications-small | 1 |
42 | dalteparin-sodium | 2 |
43 | utermohlen | 1 |
44 | move-in | 6 |
45 | paramomycin | 4 |
46 | alpha-casein | 5 |
47 | 360min | 2 |
48 | muroctasin | 3 |
49 | azilsartan-gln | 2 |
50 | alt≥3×uln | 3 |
51 | re-circumcision | 1 |
52 | re-excision | 20 |
53 | reexcision | 11 |
54 | laparoconversion | 5 |
55 | re-admission | 88 |
56 | readmission | 1,208 |
57 | re-intubation | 31 |
58 | reintubation | 139 |
59 | hot-consolidation | 2 |
60 | re-manipulation | 1 |
61 | incarceration | 173 |
62 | reincarceration | 7 |
63 | re-operation | 228 |
64 | reoperation | 1,177 |
65 | re-exploration | 49 |
66 | reexploration | 24 |
67 | hospitalisation | 1,149 |
68 | re-hospitalisation | 24 |
69 | rehospitalisation | 57 |
70 | re-catheterisation | 5 |
71 | recatheterisation | 14 |
72 | re-consultation | 8 |
73 | hospitalization | 7,776 |
74 | re-hospitalization | 91 |
75 | intervention/hospitalization | 1 |
76 | event/hospitalization | 2 |
77 | rehospitalization | 550 |
78 | re-catheterization | 15 |
79 | recatheterization | 41 |
80 | recall/repetition | 1 |
81 | re-intervention | 98 |
82 | nurse-intervention | 1 |
83 | reintervention | 310 |
84 | peri-conception | 3 |
85 | trial.†ep | 1 |
86 | questionnaire-mlhfq | 1 |
87 | cbmcr | 9 |
88 | autumn/winter | 3 |
89 | hypotensor | 2 |
90 | anti-saccades | 4 |
91 | stoppages | 2 |
92 | adenotonsillectomies | 18 |
93 | treatment-failures | 2 |
94 | thermoactinomycetes | 2 |
95 | false-negatives | 8 |
96 | polydrugs | 2 |
97 | five-months | 2 |
98 | 70months | 2 |
99 | ofosteosynthesis | 1 |
100 | rubricytosis | 3 |
101 | retocolysis | 4 |
102 | urethrolysis | 5 |
103 | handbacks | 1 |
104 | handrails | 2 |
105 | re-admissions | 39 |
106 | readmissions | 548 |
107 | reoperations | 281 |
108 | hospitalisations | 352 |
109 | depolarisations | 6 |
110 | reconsultations | 9 |
111 | re-transplantations | 1 |
112 | hospitalizations | 2,187 |
113 | re-hospitalizations | 18 |
114 | rehospitalizations | 136 |
115 | re-interventions | 25 |
116 | reinterventions | 96 |
117 | 3.5years | 3 |
118 | pressors | 8 |
119 | tients | 2 |
120 | squirts | 4 |
121 | refavs | 2 |
122 | antimicrobial-days | 2 |
123 | re-transplant | 2 |
124 | inquest | 5 |
125 | death/htx | 7 |
126 | april-july | 1 |
127 | orchectomy | 1 |
128 | re-laparotomy | 28 |
129 | immunotherapy/biotherapy | 4 |
130 | interval-to-delivery | 1 |
131 | no-mdd-history | 2 |
132 | piezoelectricity | 2 |
133 | frigidity | 3 |
134 | quantifiability | 2 |
135 | canalplasty | 3 |
136 | pieloplasty | 1 |
137 | ductoplasty | 1 |